Abstract
Современные подходы позволяют сохранять репродуктивную функцию у молодых пациентов с различными онкологическими заболеваниями. В обзоре освещен отечественный и зарубежный опыт по сохранению репродуктивной функции путем заморозки сперматозоидов, ткани яичника, эмбрионов и ооцитов.References
Адамян Л.В., Жордания К.И., Белобородов С.М. Репродуктивная функция у онкологических больных. Как сохранить возможность иметь детей // Вопр. онкол. — 2004. — Т. 50. — № 3. — С. 279-292.
Баркалина Н.В., Ревишвили Н.А., Назаренко Т.А. Криоконсервация ткани яичников: метод сохранения генетического материала для отсроченной реализации репродуктивной функции // Пробл. репрод. — 2010. — Т. 16. — № 2. — C. 30-33.
Бахидзе Е.В. Фертильность, беременность и гинекологический рак. - Москва-Санкт-Петербург — 2004. - 288 с.
Быстрова О.В., Диникина Ю.В., Тапильская Н.И. и др. Криоконсервация овариальной ткани у пациенток со злокачественными и доброкачественными новообразованиями органов репродуктивной системы // журнал акуш. и женск. болезней. — 2006. — Т. 55. — № 4. - С. 63-69.
Быстрова О.В., Калугина А.С., Цыбатова Е.В. и др. Способы восстановления фертильности у онкологических больных // Прак. онкология. (Злокачественные опухоли и беременность). — 2009. — Т. 10. — № 4. — C. 245-253.
Максимов С.Я. Минимальный рак эндометрия / Под ред. Я. В. Бохмана. СПб.: Гиппократ. - 1994. — 149 с.
Назаренко Т.А., Ревишвили Н.А., Камалетдинов Н.С. и др. Получение и сохранение генетического материала у больных раком молочной железы (первый опыт) // Пробл. репродукции. — 2010. — Т. 16. — № 6. — с. 69-74.
Amorim C., Curaba M., Van Langendonckt A. et al. Vitrification as an alternative means of cryopreserving ovarian tissue // Reprod. Biomed. Online. — 2011. — Vol. 23. — P. 160-186.
Anderson R., Cameron D. Pretreatment serum anti-müllerian hormone predicts long-term ovarian function and bone mass after chemotherapy for early breast cancer // J. Clin. Endocrinol. Metab. — 2011. — Vol. 96. — P. 1336-1343.
Anderson R., Wallace W., Baird D. Ovarian cryopreservation for fertility preservation: indications and outcomes // Reproduction. — 2008. — Vol. 136. — P. 681-689.
Aubard Y. Ovarian tissue xenografting // Eur. J. Obstet. Gynecol. Reprod. Biol. — 2003. - Vol. 108. — P. 14-18.
Bath L., Critchley H., Chambers S. et al. Ovarian and uterine characteristics after total body irradiation in childhood and adolescence: response to sex steroid replacement // Brit. J. Obstet. Gynaecol. — 1999. — Vol. 106. — P. 1265-1272.
Bedaiwy M., Abou-Setta A., Desai N. et al. Gonadotropin-releasing hormone analog cotreatment for preservation of ovarian function during gonadotoxic chemotherapy: a systematic review and meta-analysis // Fertil. Steril. — 2011. — Vol. 95. — P. 906-14.e1-4.
Blumenfeld Z. Preservation of ovarian function and minimizing premature ovarian failure during chemotherapy using gonadotropin-releasing hormone analogs // Womens Health (Lond.Engl.). — 2011. — Vol. 7. — P. 635-640.
Blumenfeld Z., Haim N. Prevention of gonadal damage during cytotoxic therapy // Ann. Med. — 1997. — Vol. 29. — N 3. — P. 199-206.
Brown J.R., Modell E., Obasaju M., King Y.K. Natural cycle in-vitro fertilization with embryo cryopreservation prior to chemotherapy for carcinoma of the breast // Hum. Reprod. - 1996. — Vol.11. — P. 197-199.
Cobo A., Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials // Fertil. Steril. — 2011. — Vol. 96. — P. 277-285.
Critchley H., Wallace H. Impact of cancer treatment on uterine function // J.Natl.Cancer Inst.Monogr. — 2005. — Vol. 34. — P. 64-68.
Decanter C., Morschhauser F., Pigny P. et al. Anti-M llerian hormone follow-up in young women treated by chemotherapy for lymphoma: preliminary results // Reprod. Biomed. Online. — 2010. — Vol. 20. — P. 280-285.
Donnez J., Jadoul P., Squifflet J. et al. Ovarian tissue cryopreservation and transplantation in cancer patients // Best Pract. Res. Clin. Obstet. Gynaecol. - 2010. — Vol. 24. — P. 87-100.
Donnez J., Silber S., Andersen C. et al. Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births // Ann. Med. — 2011. — Vol. 43. — р. 437-450.
Friedler S., Koc O., Gidoni Y. et al. Ovarian response to stimulation for fertility preservation in women with malignant disease: a systematic review and meta-analysis // Fertil. Steril. - 2012. - Vol. 97. - P. 125-133.
Gook D., Edgar D., Borg J. et al. Oocyte maturation, follicle rupture and luteinization in human cryopreserved ovarian tissue following xenografting // Hum. Reprod. — 2003. — Vol. 18. — P. 1772-1781.
Green D., Nolan V., Kawashima T. et al. Decreased fertility among female childhood cancer survivors who received 22-27 Gy hypothalamic/pituitary irradiation: a report from the Childhood Cancer Survivor Study // Fertil. Steril. — 2011. — Vol. 95. — P. 1922-1927.e1.
Holoch P., Wald M. Current options for preservation of fertility in the male // Fertil. Steril. - 2011. — Vol. 96. — P. 286-290.
Howell S., Shalet S. Spermatogenesis after cancer treatment: damage and recovery // J. Natl. Cancer Inst. Monogr. — 2005. — Vol. 34. — P. 12-17.
Humaidan P., Kol S., Papanikolaou E., Copenhagen GnRH Agonist Triggering Workshop Group GnRH agonist for triggering of final oocyte maturation: time for a change of practice? // Hum. Reprod. Update. — 2011. — Vol. 17. — P. 510-524.
Janse F., Donnez J., Anckaert E. et al. Limited value of ovarian function markers following orthotopic transplantation of ovarian tissue after gonadotoxic treatment // J Clin Endocrinol Metab. — 2011. — Vol. 96. — P. 1136-1144.
Keros V., Xella S., Hultenby K. et al. Vitrification versus controlled-rate freezing in cryopreservation of human ovarian tissue // Hum. Reprod. — 2009. — Vol. 24. — P. 1670-1683.
Kim S., Klemp J., Fabian C. Breast cancer and fertility preservation // Fertil. Steril. — 2011. — Vol. 95. — P. 1535-1543.
Knopman J., Papadopoulos E., Grifo J. et al. Surviving childhood and reproductive-age malignancy: effects on fertility and future parenthood // Lancet Oncol. — 2010. — Vol. 11. — P. 490-498.
Kyono K., Doshida M., Toya M. et al. Potential indications for ovarian autotransplantation based on the analysis of 5,571 autopsy findings of females under the age of 40 in Japan // Fertil. Steril. — 2010. — Vol. 93. — P. 2429-2430.
Loibl S., Gerber B. Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer // JAMA. — 2011. — Vol. 306. — P. 1760.
Lotz L., Montag M., van der Ven H. et al. Xenotransplantation of cryopreserved ovarian tissue from patients with ovarian tumors into SCID mice--no evidence of malignant cell contamination // Fertil. Steril. - 2011. — Vol. 95. — P. 2612-4.e1.
Meirow D., Dor J., Kaufman B. et al. Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury // Hum. Reprod. — 2007. — Vol. 22. — P. 1626-1633.
Oktay K, Buyuk E, Libertella N. et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation // J. Clin. Oncol. — 2005. — Vol. 23. — P. 4347-4353.
Oktay K., Arslan E., Karsy M., Moy F. Safety of pregnancy after letrozole-FSH stimulation in breast cancer patients: a prospective comparison of frozen embryo transfer to self vs. gestational carriers // Fertil. Steril. — 2011. — Vol. 96. — Suppl. — P. S42-S43.
Oktay K., S nmezer M., Oktem O. et al. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemotherapy-induced gonadal injury // Oncologist. — 2007. — Vol. 12. — P. 1055-1066.
Redig A., Brannigan R., Stryker S. et al. Incorporating fertility preservation into the care of young oncology patients // Cancer. — 2011. — Vol. 117. — P. 4-10.
Robit A., Abir R., Feinmesser M. et al. Occasional involvement of the ovary in Ewing sarcoma // Hum. Reprod. — 2010. — Vol. 25. — P. 1708-1712.
Rodriguez-Wallberg K., Oktay K. Fertility preservation medicine: options for young adults and children with cancer // J. Pediatr. Hematol. Oncol. — 2010. — Vol. 32. — N 5. - P. 390-396.
Rosendahl M., Andersen M., Ralfkiær E. et al. Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia // Fertil. Steril. — 2010. — Vol. 94. — P. 2186-2190.
Rosendahl M., Schmidt K., Ernst E. et al. Cryopreservation of ovarian tissue for a decade in Denmark: a view of the technique // Reprod. Biomed. Online. — 2011. — Vol. 22. — P. 162-171.
Schmidt K., Nyboe Andersen A., Greve T. al. Fertility after chemotherapy in 143 women who prior to treatment had one ovary cryopreserved for fertility preservation // Hum. Reprod. — 2011. — Vol. 26. — Suppl. 1. - P. i15.
Sonmezer M., Oktay K. Fertility preservation in female patients // Hum. Reprod. Update. — 2004. — Vol. 10. — P. 251-266.
Sonmezer M., Oktay K. // Best Pract. Res. Clin. Obstet. Gynaecol. — 2010. — Vol. 24. - P. 113-126.
von Wolff M., Donnez J., Hovatta O. et al. Cryopreservation and autotransplantation of human ovarian tissue prior to cytotoxic therapy--a technique in its infancy but already successful in fertility preservation // Eur. J. Cancer. — 2009. — Vol. 45. — P. 1547-1553.
von Wolff M., Montag M., Dittrich R. et al. Fertility preservation in women--a practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin‘s lymphoma and borderline ovarian tumours by the fertility preservation network Ferti-PROTEKT // Arch. Gynecol. Obstet. — 2011. — Vol. 284. — P. 427-435.
von Wolff M., Thaler C., Frambach T. et al. Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase // Fertil. Steril. — 2009. — Vol. 92. — P. 1360-1365.
Wallace W., Thomson A., Saran F., Kelsey T. Predicting age of ovarian failure after radiation to a field that includes the ovaries // Int. J. Radiat. Oncol. Biol. Phys. — 2005. — Vol. 62. — P. 738-744.
All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...